People who undergo repeated surgeries to remove glioblastomas - the most aggressive and deadliest type of brain tumours - may survive longer than those who have just a one-time operation, new Johns Hopkins research suggests.
Glioblastoma, the brain cancer that killed Sen Edward Kennedy, inevitably returns after tumour-removal surgery, chemotherapy, and / or radiation. The median survival time after diagnosis is only 14 months.
With recurrence a near certainty, experts say, many have questioned the value of performing second, third or even fourth operations, especially given the dangers of brain surgery, including the risk of neurological injury or death.
"We are reluctant to operate on patients with brain cancer multiple times as we are afraid to incur new neurological deficits or poor wound healing, and many times we are pessimistic about the survival chances of these patients," says Alfredo Quinones-Hinojosa, MD, a professor of neurosurgery at the Johns Hopkins University School of Medicine and leader of the study published recently in the Journal of Neurosurgery.
"But this study tells us that the more we operate, the longer they may survive. We should not give up on these patients."
For the study, Quinones-Hinojosa and his team reviewed the records of 578 patients who underwent surgery to remove a glioblastoma between 1997 and 2007 at The Johns Hopkins Hospital. At the last follow-up, 354 patients had one surgery, 168 had two resections, and 41 and 15 patients had three and four operations, respectively. The median survival for patients who underwent one, two, three and four operations was 6.8 months, 15.5 months, 22.4 months and 26.6 months, respectively.